Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 243 clinical trials in Breda, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study on Switching from Dulaglutide to Tirzepatide for Adults with Type 2 Diabetes
BelgiumStudy of Ivosidenib for Patients with Previously Treated Advanced or Metastatic Cholangiocarcinoma
The NetherlandsStudy Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Melanoma
AustriaStudy Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence
The NetherlandsStudy on the Safety of Ivosidenib and Azacitidine for Adults with Newly Diagnosed IDH1m Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy
The NetherlandsStudy on the Safety and Effectiveness of Filgotinib for Patients with Refractory Behcet's Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease
The NetherlandsStudy comparing XL092 plus nivolumab versus sunitinib for patients with advanced or metastatic non-clear cell kidney cancer
The NetherlandsStudy on Irinotecan and mFOLFOX4-Bevacizumab for Patients with Resectable Colorectal Peritoneal Metastases
The NetherlandsEvaluation of Long-Term Efficacy and Safety of Obefazimod as Maintenance Therapy in Patients with Moderately to Severely Active Ulcerative Colitis
The NetherlandsOral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type
The NetherlandsStudy on Lorundrostat for Patients with Uncontrolled and Resistant Hypertension
The NetherlandsEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on multiple myeloma, breast cancer, and leukemia treatments. Studies evaluate novel drug combinations and targeted therapies to improve patient outcomes.
Investigations include combination therapies and treatment discontinuation strategies for various cancer types.
Research focusing on coronary artery disease and post-procedural care, including innovative diagnostic techniques and antithrombotic strategies.
Emphasis on personalized treatment approaches and diagnostic accuracy improvement.
Clinical trials examining respiratory infections and chronic conditions, including vaccine development and asthma management strategies.
Focus on both preventive measures and treatment optimizations for respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
